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ABSTRACT 
 
OBJECTIVE: To determine the incidence of intrapartum asphyxia and hypoxic ischemic 
encephalopathy (HIE) and predictors of poor outcome in term and near term infants in a 
hospital from a developing country. 
 
METHODS: Neonates with birth weight ≥2000g who required bag mask ventilation and 
were admitted with a primary diagnosis of intrapartum asphyxia from January-to-
December 2011 were included. Medical records were retrieved, maternal and infant data 
were collected and analysed. Comparison between infants with severe HIE and/or died and 
those who survived normal or with mild to moderate HIE was performed.   
 
RESULTS: There were 21086 live births with birth weight of ≥2000 grams over this 
period, the incidence of intrapartum asphyxia varied from 8.7 to 15.2/ 1000 live births and 
that of HIE from 8.5 to 13.3/ 1000 live births based on definition of intrapartum asphyxia 
used. Sixty percent of patients with HIE had moderate to severe HIE. Overall mortality 
rate was 7.8-12.3% (dependent on definition used) and 14.2% when including the deaths 
from labour ward. Mortality rate in infants with moderate and severe HIE was 7.1%, and 
62.5% respectively. Odds of severe HIE and/or death were high if Apgar score was <5 at 
10 minutes (OR 19.1; 95% CI 5.7;66.9), no spontaneous respiration at 20 minutes (OR 
27.2; 95% CI 6.9;117.4), need for chest compressions (OR 8.37; 95% CI 3.71;19.1), need 
for adrenalin (OR 81.2; 95% CI 13.2;647.7) and pH<7 (OR 5.33; 95% CI 1.31;25.16). 
Predictors of poor outcome ( namely severe HIE and/or death) were Apgar score at 10 
minutes (p=0.004), adrenaline (p=0.034) and low serum bicarbonate (p=0.028). 
 
CONCLUSION: Incidence of intrapartum asphyxia in term and near-term infants is 
higher than that reported in developed countries. Low Apgar score at 10 minutes and the 
need for adrenalin remain important factors in predicting poor outcome in infants with 
intrapartum asphyxia. 
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PART A- PROTOCOL 
Introduction  
 
There are different criterions that have been used to make a diagnosis of intrapartum 
asphyxia, some simple and some more complex. The more strict or complex criteria to 
diagnose intrapartum asphyxia is that described by the American Academy of 
Paediatrics (AAP) and American College of Obstetrics and Gynaecology (ACOG) in 
1996.
[1]
 These criteria state that the following must be present for the diagnosis of 
intrapartum asphyxia; 1) profound metabolic or mixed academia (pH<7) in an umbilical 
artery blood sample, 2) persistence of an Apgar score of 0-3 for longer than 5 minutes, 
3) neonatal neurologic sequelae (e.g., seizures, coma, hypotonia), 4) multiple organ 
involvement (e.g., kidney, lungs, liver, heart, intestines). Simple criterion that have been 
used to diagnose intrapartum asphyxia have included the failure to initiate 
regular respiration within a minute of birth, Apgar score less than 7 at 5 minutes, and 
the need for bag mask ventilation or resuscitation at birth.
[2]
 These simple criteria are 
based on the fact that newborn infants usually initiate breathing without assistance and 
usually cry after delivery. By one minute after birth most infants are breathing normally. 
Successful transition from intrauterine to extrauterine life requires a newborn baby to 
initiate spontaneous breathing at time of birth. Most term infants will initiate 
spontaneous respiration without any form of assistance. It has been reported that 5-10% 
of newborns will require stimulation, 3-6 % will require bag mask ventilation and less 
than 1% will require chest compressions, intubation and adrenaline.
[3] 
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Intrapartum asphyxia is one of the major causes of death and/ or neurologic impairment 
in children, therefore using a less strict definition that can be used even in clinical 
settings where one has no access to do blood gases may increase the sensitivity of 
diagnosis of intrapartum asphyxia. The newborns who fail to initiate spontaneous 
respiration are more likely to die or have brain damage. Among the patients who die, a 
number of them will die during the neonatal period depending on the severity of brain 
injury. Globally, it is estimated that about 3.3 million neonates died in 2009.
[4]
 In South 
Africa there were 14 000 neonatal deaths in 2008. About a quarter of neonatal deaths 
are due to intrapartum asphyxia. The fifth perinatal care survey in South Africa reported 
that the causes of death among infants who died from intrapartum asphyxia 50% were 
due to hypoxic ischemic encephalopathy, 28% due to  meconium aspiration syndrome 
and 18% due to persistent pulmonary hypertension of the newborn.
[5]
 Though it is 
known how many neonatal deaths are due to intrapartum asphyxia in South Africa, 
there have been no reports as to how many babies are diagnosed with a problem of 
intrapartum asphyxia in our healthcare facilities and how many survive with 
complications associated with intrapartum asphyxia especially Hypoxic Ischemic 
Encephalopathy (HIE) which is more likely to be associated with long term neurologic 
impairment. Fifteen to 20% of those infants with HIE die in the neonatal period and 25-
30% of those infants who survive develop permanent neurodevelopmental deficits e.g. 
cerebral palsy.
[6]
 
Hypoxic ischemic encephalopathy is divided into 3 grades of severity that have a 
predictable outcome.
[7, 8]
 Unfortunately, the grade of HIE can only be assigned when the 
encephalopathy is established. With newer interventions, the outcome could possibly 
change appreciably which is why early therapeutic intervention in the asphyxiated 
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babies may be imperative to decrease cerebral injury and prevent further complications. 
Therefore, there remains a need to identify characteristics that are associated with 
severe HIE or death in asphyxiated infants as these infants might benefit from 
therapeutic hypothermia. The factors associated with poor outcome have been identified 
in previous studies but most of these studies have been conducted in developed world. It 
is possible that the factors associated with poor outcome in developed countries are not 
the same as those in developing countries. For example infection has been identified to 
result in abnormal neurodevelopmental outcome and its role in patients who develop 
HIE post-asphyxia is not known and infections are more prevalent in developing 
countries than in developed countries. Therefore understanding the burden and 
outcomes of intrapartum asphyxia is important, so that one can be able to assess how 
much assistance is required towards its reduction and to identify factors associated with 
poor outcomes.
[9]
  
Poor outcome and characteristics of asphyxiated babies are dependent on numerous 
antenatal antecedents which can affect the fetus at different gestational ages from a 
specific gestational age e.g. term or preterm, to those affecting the fetus at any 
gestational age. In this study the focus will be on some of the antecedent factors 
associated with term/ near term babies born with asphyxia neonatorum which include 
parity/gravity, maternal age, patient booked/booking bloods, maternal conditions e.g. 
pregnancy induced hypertension/pre-eclampsia, diabetes mellitus and chorioamnionitis/ 
intrauterine infection/ inflammation. Some aspects of the impact of obstetric care will 
be looked at namely mode of delivery (caesarian section, normal vaginal delivery, and 
breech), assisted delivery and cardiotocograph (CTG) performed and interpretation 
thereof. The antenatal events are either directly responsible for brain damage to the 
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infant or make the infant more vulnerable to the normal asphyxiating events during 
delivery.
[10]
 
Justification for the study 
The number, characteristics, and outcome of patients who require resuscitation in 
developing countries are not well documented. A number of patients who need 
resuscitation at birth might benefit from therapeutic hypothermia, therefore it is 
important to determine characteristics of patients who die or develop severe HIE. Chris 
Hani Baragwanath Academic Hospital where this study will be conducted has about 
23000 births a year, making it one of the busiest hospitals in the country.  It caters for 
different types of patients, the majority (about two thirds) being high risk patients and 
about a third low risk patients and with some of them presenting in advanced stage of 
labour. The large number of births in relation to the number of midwives, obstetric and 
paediatric doctors places a high burden on perinatal care which results in delays in 
detecting those who need assistance and further care. In this environment it is more 
likely that the number of babies who need resuscitation (defined as need for bag mask 
resuscitation) are most likely to be higher than that reported in the literature. Delays in 
detecting those with fetal distress are more likely associated with high risk of brain 
injury despite resuscitation. The characteristics of those who need resuscitation and 
have signs of brain injury and/ or death or factors associated with poor outcomes in 
asphyxiated patients in our hospital are not known.   
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Objectives 
 
 To determine the number of patients admitted with diagnosis of intrapartum 
asphyxia at CHBAH. 
 To describe the characteristics of patients diagnosed with intrapartum asphyxia.  
 To determine the number of patients who have HIE secondary to intrapartum 
asphyxia 
 To determine the number of patient who die from asphyxia-related 
complications 
 To compare the characteristics of patients who had severe HIE or death to those 
who survived to hospital discharge with no HIE or mild to moderate HIE 
 
Definitions 
 
 Near-term and term infants -- Gestational age >33 weeks according to obstetric 
records and/ or weight >2000grams 
 Intrapartum asphyxia -- patient who required bag mask ventilation (BMV) or 
more at birth and subsequently admitted to TICU (level 2 nursery) or NICU 
(level 3 nursery) with a diagnosis of asphyxia. 
 No HIE - No diagnosis of HIE or signs suggestive of HIE documented in the 
patients’ notes 
 HIE I, II, III – according to label in the hospital record or according to presence 
of signs that define HIE I, II, III in Sarnat staging (see Table1)  
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Table 1 Sarnat and Sarnat classification for Hypoxic Ischemic Encephalopathy 
   Grade 1 Grade 2 Grade 3 
Level of 
Consciousness 
Hyperalert Lethargic or obtunded Stuporous 
Neuromuscular Control 
Muscle tone Normal Mild hypotonia Flaccid 
Posture Mild distal flexion Strong distal flexion Intermittent 
decerebration 
Stretch reflexes Overactive Overactive Decreased or absent 
Segmental 
myoclonus 
Present Present Absent 
Suck Weak Weak or absent Absent 
Moro Strong; low 
threshold 
Weak; incomplete; 
high threshold 
Absent 
Oculovestibular Normal Overactive Weak or absent 
Tonic neck Slight Strong Absent 
Autonomic Function Generalized 
sympathetic 
Generalized 
parasympathetic 
Both systems 
depressed 
Pupils Mydriasis Miosis Variable; often 
unequal; poor light 
reflex 
Heart Rate Tachycardia Bradycardia Variable 
Bronchial and 
Salivary  
Secretions 
Sparse Profuse Variable 
GI Motility Normal or 
decreased 
Increased; diarrhoea Variable 
Seizures None Common; focal or 
multifocal 
Uncommon 
(excluding 
decerebration) 
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Methods 
Study Design 
 
It will be a descriptive study, conducted through a retrospective review of  medical 
records of neonates born at >33 weeks and/ or weighing 2000 g who required 
resuscitation with at least bag mask ventilation at birth and were admitted to level 2 or 3 
nursery with a primary diagnosis of intrapartum asphyxia from 1
st
  January to 31
st
  
December 2011.  
Sample Population 
 
The sample population includes all neonates born at a gestational age >33 weeks and/ or 
weighing 2000 g born at Chris Hani Baragwanath Academic Hospital (CHBAH)  
Inclusion Criteria 
 
Neonates who required resuscitation with at least bag mask ventilation and admission to 
levels 2 or 3 nursery NICU or died in labour ward with a diagnosis of intrapartum 
asphyxia 
Exclusion Criteria 
 
 Infants born before arrival to CHBAH 
 Infants weighing <2000 g 
 Infants with severe congenital abnormalities  
 Twin pregnancies 
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Procedures/ Data Collection 
 
Records of patients who were admitted to high care or Neonatal Intensive Care Unit 
(NICU) from 1 January to 31 December 2011 will be reviewed to select those that have 
the information that met the above criteria. Records with information that met the above 
criteria will be included in the study. The data will be collected and entered onto a 
prepared data sheet (appendix A). The data sheet will capture demographic information 
(Maternal age, parity, maternal Human Immunodeficiency Virus (HIV) and Rapid 
Plasma Reagen (RPR) status,  infants’ birth weight, gender, Apgar score), presence of 
abnormal neurologic signs, clinical diagnoses, duration of stay and investigations (blood 
gases, Full Blood Count (FBC) +Platelets, C-Reactive Protein (CRP), Lumbar Puncture 
(LP), Urea and Electrolytes  (U&E), Creatinine, Ca+Mg+PO4), died or survived.  
Data Analysis 
 
Data will be entered into a Microsoft Excel spreadsheet and basic statistical analysis 
will be performed using Microsoft Excel. Appropriate descriptive statistical analysis 
using percentages, means and standard deviations and medians and ranges will be used 
for demographic data. For analysis looking at comparisons between those who died or 
with severe HIE and those who survived with no or mild to moderate HIE, Chi square 
or Fischer’s exact test will be used to compare categorical variables and Student t-test or 
Mann Whitney U test will be used to compare the continuous variables using STATA. 
A statistician will be consulted for further assistance if needed. 
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Significance 
 
The findings of this study will be shared with both obstetric and paediatric teams to 
highlight any improvements to perinatal care of mother and baby. Identifying the 
incidence of intrapartum asphyxia, characteristics related to maternal factors and 
obstetric care and outcome of infants with intrapartum asphyxia will assist in 
highlighting the need to improve obstetric care and/or paediatric care in our hospital and 
South Africa at large.  
 Limitations 
 
The study is a retrospective audit of records and thus relies on data from existing 
records. These records may not be complete and some might be missing and therefore 
might weaken the validity of the findings.  Infants who died in labour ward (36) were 
not included in the statistical calculation due to the absence of the files.    
Ethical Considerations 
 
The proposal for this study will be submitted to the CHBAH Protocol Review 
Committee and Human Research Ethics Committee (HREC) of the University of the 
Witwatersrand for approval. As this is a retrospective audit, no consent will need to be 
obtained from individual patients. Data sheets will only contain a study number. The 
patient’s name and file numbers will be stored in a separate database at a different, 
secure location so that only the investigator and the supervisor will have access to this 
information. The study will not be started until clearance from the ethics and hospital 
committee has been received.  
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Cost/Funding 
The cost involved in the study is for stationery, printing and binding. This cost will be 
borne by the investigator as there is no funding for this study. 
Time Lines 
  
Feb 
2012 
Mar 
2012 
Apr 
2012 
May 
2012 
Jun 
2012 
Jul 
2012 
Aug 
2012 
Sep 
2012 
Oct 
2012 
Nov 
2012 
literature 
review                     
protocol 
preparation                     
protocol 
assessment                     
ethics 
approval                     
post 
graduate 
approval                     
data 
collection                     
data 
analysis                     
write-up 
report                     
write-up 
paper                     
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PART B- MAIN RESEARCH REPORT 
 
CHAPTER 1.0 – LITERATURE REVIEW 
1.1 Introduction 
 
Intrapartum asphyxia is defined biochemically as a condition of impaired respiratory 
gaseous exchange that results in hypoxemia, hypercapnia and metabolic acidosis. 
Metabolic acidaemia defined as a base deficit of >12 mmol/L or pH <7 has been 
associated with the presence of intrapartum asphyxia episodes; therefore it has been 
used to define intrapartum asphyxia biochemically.
[1]
 The problem with this definition 
is that a number of normal babies have metabolic acidosis therefore used on its own 
there is a risk that it might overestimate or underestimate the incidence of intrapartum  
asphyxia.
[2]  
Lower thresholds have been shown to be more sensitive. Clinically, the need for bag 
mask ventilation (BMV) at birth and/or an Apgar score <7 have been used to define 
intrapartum asphyxia.
[3]
 Since, in many developing countries there are no facilities to do 
blood gas measurement, base deficit is not used as part of the definition and only the 
clinical definition is used. Using the clinical definition alone to describe the incidence 
of asphyxia might also overestimate the incidence as infants who do not initiate 
respiration are not always asphyxiated intrapartum. Therefore assessing incidence of 
intrapartum asphyxia using a combination of clinical definition of need for BMV, Apgar 
score <7 at 5 minutes and metabolic acidaemia (base deficit of >12 mmol/L and/or pH 
<7.0) is more likely to provide information as to the true incidence of intrapartum 
asphyxia in the studied population.  
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Neonates with intrapartum asphyxia often have ongoing respiratory depression requiring 
respiratory support in a neonatal intensive care unit. Where resources are limited, there 
is competition for these interventions resulting in rationing and offering them to those 
who are more likely to survive with minimal morbidity. Therefore it is important to 
determine factors that are associated with severe morbidity and mortality as they might 
assist in decision-making with regard to who should be offered these limited resources.  
 
1.2 Definitions 
1.2.1 Perinatal asphyxia 
 
Intrapartum  asphyxia can be defined as “a clinical situation of damaging acidaemia, 
hypoxia, and metabolic acidosis”. This definition is not cause specific but by adding the 
prerequisite for an identifiable significant event capable of interrupting oxygen supply 
to the fetus or infant a more accurate definition can be formed
.[4]
 Simple criterion that 
have been used to diagnose asphyxia have included failure to start regular respiration 
within a minute of birth, Apgar score less than 7 at 5 minutes, and need for bag mask 
ventilation or resuscitation at birth.
[3]
 The simple criteria are based on the fact that 
newborn infants usually initiate breathing without assistance and usually cry after 
delivery. A stricter and more complex system for the diagnosis of intrapartum asphyxia 
was described by the American Academy of Paediatrics (AAP) and American College 
of Obstetrics and Gynaecology (ACOG) in 1996.  The definition states that all of the 
following must be present for the diagnosis of intrapartum asphyxia; profound 
metabolic or mixed academia(pH <7) in an umbilical artery blood sample, persistence 
of an Apgar score of 0-3 for longer than 5 minutes, neonatal neurologic sequelae (e.g., 
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seizures, coma, hypotonia) and multiple organ involvement (e.g., kidney, lungs, liver, 
heart, intestines).
[5]
 
However, it was later demonstrated that many neonates who were neurological injured 
as a result of intrapartum asphyxia were not detected with the use of these criteria. In 
1999, both the International Cerebral palsy Task Force and the American College of 
Obstetricians and Gynaecologists Task Force on Neonatal Encephalopathy and Cerebral 
Palsy further reinforced the criteria by adding an extension to the ACOG criteria. These 
included the following updates.
[6]
 
1. Evidence of a metabolic acidosis in fetal umbilical cord arterial blood obtained 
at delivery ( ph<7 and base deficit >12 mmols/l) 
2. Onset of neonatal encephalopathy within 24 hours 
3. Cerebral palsy of spastic quadriplegic or dyskinetic type 
4. Exclusion of other identifiable aetiologies, such as trauma, coagulation 
disorders, infectious conditions, or genetic disorders 
The above essential criteria where further updated in 2003 by the ACOG and AAP by 
including 5 additional criteria that if present together with the above 4 essential criteria 
point toward an intrapartum timing of asphyxia on their own are nonspecific to 
asphyxial insult namely 
1. A sentinel hypoxic event occurring immediate before or during labour  
2. A sudden and sustained fetal bradycardia or other evidence of a non-reassuring 
fetal status  
3. Apgar score of 0-3 beyond 5 minutes 
4. Multisystem failure with 72 hours of birth 
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5. Early imaging study showing evidence of acute non focal cerebral abnormality 
Using these criteria, all 4 essential criterion must be met before an intrapartum hypoxic 
cause of cerebral palsy can be considered whereas at least 3 of the 5 additional criterion 
have to be present to suggest an acute event rather than longer standing hypoxia or other 
chronic pathology.
[7]
 If any one of the essential criteria is not fulfilled, it might show 
that intrapartum hypoxia was not the cause of cerebral palsy. This is vital since labelling 
an infant with hypoxic-ischemic encephalopathy from intrapartum  asphyxia without 
these criteria may cause one to misdiagnose the real cause of the neurological problem 
and mismanage the neonate thereafter. Intrapartum asphyxia is one of the major causes 
of death and/ or neurologic impairment in children, therefore using a less strict 
definition that can be used even in clinical settings where one has no access to do blood 
gases will assist in highlighting the problem of intrapartum asphyxia.   
 
1.2.2 Hypoxic ischemic encephalopathy 
 
Neonatal encephalopathy is a clinically defined syndrome of impaired neurological 
function in the infant at or near term during the first week after birth. It presents with 
impaired initiation and maintenance of respiration, depression of tone and reflexes, 
altered level of consciousness and often seizures. When metabolic acidaemia has been 
conclusively proven by umbilical blood gases, fetal blood gases and or both, it must be 
established whether this is secondary to chronic hypoxia or whether an acute hypoxia 
has occurred during labour or birth in a previously healthy fetus.
[8] 
Hypoxic ischemic 
encephalopathy is divided into 3 stages of severity that have an expected outcome 
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which includes mild HIE (Grade I) which consists of jitteriness and irritability, 
moderate HIE (Grade  II) which consists of lethargy or abnormal tone ( with or without 
seizures) and severe HIE (Grade III) which consists of coma or abnormal tone and 
multiple seizures.
[9, 10] 
Unfortunately, the grade of HIE can only be assigned when the 
encephalopathy is established and at that grade no intervention can change the hypoxic 
injury already sustained but early therapeutic intervention may be imperative to 
decrease cerebral injury and prevent further complications. Therefore, there remains a 
need to identify characteristics that are associated with severe HIE or death in 
asphyxiated infants as these infants might benefit from therapeutic hypothermia. 
 
1.3 Incidence 
 
1.3.1 Perinatal asphyxia 
 
Intrapartum asphyxia is one of the major causes of death and/ or neurologic impairment 
in children. The newborns who fail to initiate spontaneous respiration are more likely to 
die or have brain damage. Among the patients who die, a number of them will die 
during the neonatal period depending on the severity of brain injury. Globally, it is 
estimated that about 3.3 million neonates died in 2009.
[11]
 In South Africa there were 14 
000 neonatal deaths in 2008. About a quarter of neonatal deaths are due to intrapartum 
asphyxia. The fifth perinatal care survey in South Africa reported that the causes of 
death among infants who died from asphyxia 50% were due to hypoxic ischemic 
encephalopathy, 28% due to meconium aspiration syndrome and 18% due to persistent 
pulmonary hypertension of the newborn.
[12]
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In 2010, The World Health Organization (WHO) published the leading causes of death 
in South African children under the age of 5 years. In this group 34% of deaths were in 
the neonatal period which included prematurity (20%), intrapartum asphyxia and trauma 
(8%), sepsis/other infectious disorders and congenital abnormalities. The latest neonatal 
mortality rate in 2012 was reported to be 15/1000 live births. In relation to developed 
country e.g. USA, 48% of under 5 deaths are in the neonatal period with a neonatal 
mortality rate of 4/1000 live births of which only 3% are due to intrapartum asphyxia. 
(WHO: World Health Statistics. Geneva, WHO, 2012.). Though it is known how many 
neonatal deaths are due to intrapartum asphyxia in South Africa, there has been no 
reports as to how many babies are diagnosed with a problem of intrapartum asphyxia in 
our healthcare facilities and how many survive with complications associated with 
intrapartum asphyxia especially HIE which is more likely to be associated with long term 
neurologic impairment.  
Whichever definition one uses, the incidence of intrapartum asphyxia in this report is 
very high compared to that reported in developed countries, which is at 1-5 / 1000 live 
births
[13-15]
. Compared to developing countries it is similar to that reported in Iceland 
(9.4/ 1000 live births)
[16]
, lower than that reported in Nigeria (28/ 1000 live births)
[17]
 
but higher than that reported from Papua New Guinea (5.5/ 1000 live births)
[18, 19]
.  We 
did not collect data on modifiable factors that might contribute to this high incidence of 
intrapartum asphyxia. 
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1.3.2 Hypoxic ischemic encephalopathy 
 
Hypoxic ischemic encephalopathy refers to the CNS dysfunction associated with 
intrapartum asphyxia, and is often the prime concern while managing asphyxiated 
neonate as it can kill the neonate and can cause significant long-term neuromotor 
sequelae in those that survive. The overall incidence of HIE is variously reported as 
between 1-6 per 1000 births, but the sequelae of who survive is known to have a graded 
effect dependent upon severity of encephalopathy.
[20]
 The incidence of moderate and 
severe forms of the disease is thought to be around 0.5-2/1000 births. Consequences of 
HIE ranging from cognitive, behavioural and memory problems to seizures and cerebral 
palsy of varying degrees and death, whilst rare in mild forms of HIE, are very high in 
the most severe forms.
[20]
 In another study based in South Africa by Horn, et al the 
incidence of HIE varied from 2.3 to 4.3 per 1000 live births; mild HIE ranged from 0.4 
to 1.3 per 1000 live births, and of moderate-severe HIE ranged from 1.5 to 3.7 per 1000 
live births.
[21]
 
 
1.4 Mortality 
 
Regarding mortality and morbidity of various HIE grades, Morris et al noted that the 
outcome of those with the most severe form of the condition is poor, with a high portion 
of grade 3 HIE infants dying or surviving only to palliative care.
[20]
 Morbidity in the 
form of abnormal neurological signs at discharge was highly prevalent in the moderate 
group, and almost universal amongst the most severe group.
[17] 
In similar vein 
Shankaran, et al found that those with moderate encephalopathy have a 10 percent risk 
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of death, and those who survive have a 30 percent risk of disabilities. Sixty percent of 
infants with severe encephalopathy die, and many who survive are handicapped.
[22] 
In 
Saudi Arabia fifteen to 20% of the infants with HIE die in the neonatal period and 25-
30% of survivors develop permanent neurodevelopmental abnormalities e.g. cerebral 
palsy.
[23] 
In severe hypoxic-ischemic encephalopathy, the mortality rate is reportedly 25-
50%. Multi-organ failure is the cause of most deaths which occur in the first week of 
life. Those infants with severe neurologic disabilities often die in their infancy 
secondary to aspiration pneumonia or systemic infections.
 [24] 
 
1.5 Factors associated with poor outcome 
 
The factors associated with poor outcome have been identified in previous studies but 
most of these studies have been conducted in developed world. It is possible that the 
factors associated with poor outcome in developed countries are not the same as those 
in developing countries. Numerous studies have reported clinical predictors within 
hours of birth for poor outcome. These include depression at birth, resuscitation and the 
responses (e.g. 5 minute Apgar score of < 3, age of establishment of spontaneous 
breathing, use of extensive resuscitation), and postnatal clinical status (age at onset of 
seizures, depressed level of consciousness).
[25]
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1.5.1 Apgar Score 
 
One of the factors associated with poor outcome is the Apgar score. The Apgar score 
was first developed in 1952 by Dr. Virginia Apgar, an obstetric anaesthesiologist.
[26]
 
Her goal was to develop a scoring system using signs observed that would gauge a 
neonate’s transition after birth. It helps to quickly and subjectively assess the condition 
of the newborn infants.  
The scoring system gained universal acceptance after it was shown to predict survival 
particularly at 5 minutes. It was then criticized when it was used as a predictor of birth 
asphyxia and long-term neurologic outcome. The problem was it didn’t take into 
account many factors which can affect the score e.g. prematurity, intubation, and 
administration of drugs to the mother which all result in low scores that are not 
indicative of asphyxia.
[27]
It is important to remember that a low Apgar score does not 
point to the cause of the poor condition which may result from numerous different 
factors of which intrapartum hypoxia is only one. On its own, the Apgar score is a poor 
predictor of neurological outcome, although the risk of poor outcome increases with 
decreasing Apgar score and increasing duration of low Apgars.
[28]
 Casey, et al examined 
whether the Apgar score was still good enough to predict survival during the neonatal 
period and if it remained pertinent in paediatric practice 50 years later. They found that 
among both preterm and term infants, those with a five minute Apgar score of 0 to 3 
had a highest risk of death. These results were in keeping with the original reports by 
Apgar.
[29]
 The importance of the Apgar score was further shown in the study by 
Laptook, et al where they look at whether the Apgar score at 10 minutes showed a 
greater correlation with death or disability in early childhood after perinatal hypoxic-
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ischemic encephalopathy. They found that there was a 45% increase in the odds of 
death or disability in those infants with Apgars at 10 minutes of 7 or less in early 
childhood.
[30]
 This further reflected the importance of the Apgar score in combination 
with other predictors of outcome in prognosticating infants after a perinatal insult has 
occurred. These studies showed that even 50 years later the Apgar score remains a 
pertinent tool in assessing the need for resuscitation at birth and remains a important 
tool in identifying those infants who are at risk of perinatal asphyxia and their 
complications thereof. 
 
1.5.2 Time to spontaneous respiration  
 
Infants are usually breathing well by one minute after birth. The successful transition 
from intrauterine to extra uterine life requires a newborn baby to initiate spontaneous 
breathing at time of birth. Most term infants will initiate spontaneous respiration 
without any form of assistance. It has been reported that 5-10% of newborns will 
require stimulation, 3-6 % will require bag mask ventilation and less than 1% will 
require chest compressions, intubation and adrenaline.
[31] 
Time to spontaneous 
respiration has been shown to be a good predictor of poor outcome in infants requiring 
resuscitation. Shah, et al looked at predictors of outcome of term infants with severe 
asphyxia comparing three variables namely base deficit, chest compressions and time to 
spontaneous respiration. They found that at an age of respiration more than 30 minutes 
had a profound (2.3 times) increase in poor outcome with regards to neurological 
complications, asphyxia related complications and/or death.
[32] 
 Pappas, et al also 
showed that time to spontaneous respiration of  more than 10 minutes was strongly 
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associated with poor outcome after adjustment to the level of PC02 levels.
[33]
 Klinger, et 
al found that there was 2.2 times greater risk for severity for those infants with 
prolonged time to initiation of respiration with a mean time of 30 minutes.
[34]
  Ekert, et 
al also showed in their study that an onset of respiration of > 10 minutes had a 5.1 times 
greater likelihood of severe adverse outcomes.
[35] 
This highlights the importance
 
of time 
to spontaneous respiration in predicting severity of outcome.
 
 
1.5.3 Need and extent of resuscitation 
 
Ten percent of newborns may require some assistance to begin breathing at birth 
whereas less than 1% require extensive resuscitative measures. Although the vast 
majority of newly born infants do not require interventions to make the transition from 
intrauterine to extra uterine life, a sizable number will require some degree of 
resuscitation. Those newborns that will need resuscitation at birth can be identified prior 
to birth by careful consideration of risk factors. If the possible need for resuscitation is 
anticipated, more skilled personnel should be alerted and the essential equipment 
prepared.
[36]
 
 
1.5.3.1 Bag Mask Ventilation 
 
Ersdal, et al looked at early initiation of basic resuscitation interventions including face 
mask ventilation to minimize birth asphyxia related mortality in low-income countries. 
They found that the majority of newborn infants delivered in a rural institution in Sub-
Saharan Africa, spontaneously started breathing within one minute and a substantial 
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number of apnoeic babies began breathing in response to basic stimulation/suction 
and/or BMV with a positive short term outcome in the majority of infants. They also 
found that 50% of the apnoeic infants responded to stimulation and suctioning only with 
a good outcome in this group. Those infants who received BMV regained spontaneous 
respiration within four to five minutes of delivery. Death was significantly more likely 
with more prolonged ventilation as well as when there was a delay in initiating BMV. 
Another important observation was that almost 10% of newborns died in the group that 
received BMV.
 [37]
 
 
1.5.3.2 Chest compressions and/ or adrenaline 
 
Both chest compressions and adrenaline have been shown to predict the severety of 
outcome of term infants with intrapartum asphyxia as seen by the following two studies. 
Shah, et al found that the administration of chest compressions for more than 10 min 
showed a 3.2 time increased risk of neurological injury and/or death. They also found 
that the use of epinephrine during the resuscitation had a 2.6 time greater risk of poor 
outcome post resuscitation.
[32]
 In similar vein Ekert, et al found that chest compressions 
at 10 minutes showed a 3.4 times greater risk for poor outcome which could be used as 
early marker (among others) of severity of asphyxia and HIE.
[35]
 
 
1.5.4 Blood gas analysis 
 
Blood gas analysis is very important in the diagnosis of intrapartum asphyxia when 
available. This should be done within one hour after birth. After an hour the newborn’s 
system may have compensated for the acidaemia. This will result in not accurately 
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evaluating the newborn for the criteria of intrapartum asphyxia and therefore a 
significant event might be missed. It is important to evaluate both the respiratory and 
metabolic components of each sample. An isolated respiratory acidosis is usually the 
result of a short-lived impairment of the uteroplacental or fetoplacental circulation and 
usually does not result in adverse outcome. Prolonged insufficiency on the other hand 
results in progressive metabolic acidosis due to anaerobic glycolysis. Consequently 
most severe fetal acidosis is mixed. 
 
1.5.4.1Base deficit and pH 
 
Base excess values have a significantly greater usefulness than umbilical cord pH 
values, because base excess does not change significantly with respiratory acidosis and 
demonstrates a linear correlation to the degree of metabolic acidosis. The change in 
hydrogen ion concentration associated with a fall in pH from 7.0 to 6.9 is almost twice 
that which leads to a fall in pH from 7.3 to 7.2. The base deficit provides a more linear 
measure of the degree of accumulation of metabolic acid and is adjusted for variation in 
PCO2.
[38]
 Low, et al initially used a measure of buffer base (<36.1 mEq/L or nearly 
equivalent base deficit <12) as an indicator of metabolic acidosis which is associated 
with newborn complications. After intrapartum asphyxia (buffer base, <34 mmol/L), the 
incidence of major or minor deficits was 20% which increased to 80% among infants 
with the most severe metabolic acidosis (buffer base,<22 mmol/L). Therefore it can be 
presumed that asphyxial injury does frequently not occur until fetal base deficit is ≤12 
mmol/L. Notably, most newborns with a base deficit of <12 mmol/L do not demonstrate 
neurologic injury. Even at levels of severe acidosis (base deficit, <16 mmol/L), most 
newborns either die or survive normally, with only a small proportion resulting in 
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cerebral palsy.
[39]
 Perlman, et al looked at base deficit as predictor of poor outcome too 
and found that a base deficit more than 16 had a two time greater risk for neurological 
abnormality and/or death.
[25]
 It was also noted that serious adverse complications in the 
newborn period are rare after birth with umbilical cord pH greater than 7.0 or base 
excess less than minus 12 mmols/l. On follow up of those infants with cord pH above 
7.0, no adverse effects where seen on cognitive outcome. Even at pH less than 7.0 most 
infants will still recover fully without remarkable consequences. In this respect, cord pH 
or base excess alone are poor predictors of outcome. Sehdev, et al looked at neonatal 
morbidity in infants with pH < 7.00. He found that those infant who had a base deficit 
>16 and a 5 minute Apgar score of <7 concurrently, identified 79% of neonates having 
complications.
[40] 
Armstrong and Stenson have noted that Goodwin, et al found that 
hypoxic ischemic encephalopathy occurred in 12% of infants with cord pH 7.0, 33% 
with cord pH 6.9, 60% with cord pH 6.8 and 80% with cord pH 6.7 or less.
[41]
 
 
1.5.4.2 Partial pressure of oxygen and carbon dioxide  
 ` 
Hypercarbia will contribute to the degree of acidosis that will be found in the initial 
blood gas analysis. This can lead to the misdiagnosis of perinatal asphyxia if only pH is 
used as inclusion criteria. Therefore pH will need to be adjusted for the level of pCO2 
before a definitive assessment can be made. On the other hand it can have a direct 
influence on severity of hypoxic ischemic encephalopathy. Both pH and pCO2 affect 
vascular tone, cerebral blood flow, cerebral oxygenation and may thereby modulate 
neuronal injury in neonates with HIE. PCO2 also contributes to decreased partial 
pressure of arterial oxygen and decrease oxygen release which has further detrimental 
effects.
[34]
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With regards to hyperoxaemia after severe intrapartum asphyxia, increased toxic free 
oxygen radicals secondary to high PaO2 mediate the adverse effects on the brain. Also 
hyperoxaemia becomes even more detrimental to the brain during the period of 
reperfusion.
[34]
 Pappas, et al found in the effect of hypocarbia on HIE with a low PaCO2 
concentration within the first 16 hours of life were associated with an increase in death 
or disability. This was directly related to the degree and severity of hypocarbia.
[33]
 
Klinger, et al looked at hyperoxaemia and/or hypocapnia during the first 2 hours of life 
and assessed whether this added to the risk of brain injury after intrapartum asphyxia. 
They found that adjusting for the severity of intrapartum asphyxia, peak PaO2 values 
exceeding 26.6 kPa (200 mm Hg) and PaCO2 values of 2.6 kPa (20 mm Hg) or lower 
during the first 20 to 120 minutes of life were associated with death or adverse 
neurodevelopmental outcome.
[34] 
 The risk of adverse outcome was greatest in subjects 
who had both. There was three times increase in risk for poor outcome with either 
severe hyperoxaemia or severe hypocapnia but more significant was a 4 time greater 
risk in those infant who had both severe hyperoxaemia and severe hypocapnia.
[34]
 
Therefore, normoxia and normocapnia should be maintained with closer monitoring and 
individualised oxygen supplementation and ventilation to avoid exacerbation of the 
damage sustained. 
In this study we sought to assess the incidence of intrapartum asphyxia and hypoxic 
ischemic encephalopathy (HIE) (according to the presence of signs that define HIE 
1,2,3 in Sarnat staging)(Table 1)
[10]
, infant characteristics and factors associated with 
severe HIE and mortality in term and near-term neonates diagnosed with intrapartum 
asphyxia in a setting where there is a high patient load and resources are limited.   
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CHAPTER 2.0 METHODS 
 
2.1 Study design: A retrospective, descriptive study of neonates born at term or 
near-term (defined as those with birth weight ≥2000 grams) and admitted with a 
diagnosis of intrapartum asphyxia. 
2.2 Study setting: The study was conducted at CHBAH a public government 
hospital. This hospital serves the population of Soweto and the surrounding areas. Until 
April 2014, it was the only hospital in Soweto. It is also a referral centre for all clinics 
conducting births in Soweto and surrounding areas. These clinics conduct about 8 000 
births per year while the hospital conducts about 23 000 births per year, with a total of 
just over 30 000 births per year for the cluster. In 2011, the hospital had two operating 
theatres for obstetric surgery including caesarean sections (CS) and twelve neonatal 
intensive care (ICU) beds.  
 
2.3 Study Population: Infants who were born weighing ≥ 2000g and required 
resuscitation with at least a bag mask ventilation (BMV) and were admitted with a 
diagnosis of intrapartum asphyxia were included. The study period was from 1
st 
January 
to 31
st 
December 2011. Infants who died in labour ward soon after birth were excluded 
as their records either were missing or had incomplete information. Patients who were 
born before arrival to hospital, twin pregnancies (due to the increased risk for 
complications of which one is intrapartum asphyxia) and those infants with severe 
congenital abnormalities were also excluded.  
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2.4 Study Procedure: Hospital records of newborn infants who met the inclusion 
criteria were retrieved and the following data were collected: birth weight, gender, 
gestational age, growth, Apgar score, resuscitation required, time to spontaneous 
respiration, arterial blood gas done within the first hour of birth and diagnosis of 
hypoxic ischemic encephalopathy. Maternal records were also reviewed for maternal 
age, parity, maternal human immunodeficiency virus results, antenatal care, maternal 
disease, mode of delivery, presence of foetal distress or meconium stained amniotic 
fluid and records of cardiotocograph. Means, standard deviations, medians and ranges 
were used to describe continuous variables while frequencies and percentages were used 
to describe categorical variables. The Chi square or Fischer’s exact tests and Student t-
test were used to compare the categorical variables and continuous variables 
respectively between infants with normal or mild to moderate HIE and those with 
severe HIE or died. Differences between the two groups were considered statistically 
significant at a p-value of <0.05. The extent of association of different variables with 
severe HIE or death was reported using odds ratios (ORs) and the precision using 95% 
confidence intervals (CIs). In order to determine predictors of severe HIE or death, 
variables with p-values <0.05 on the univariate logistic regression were included in the 
multivariate logistic regression. STATA version 10.0. was used to perform the 
statistical analysis. The approval to conduct the study was obtained from the hospital 
protocol review committee and the University of the Witwatersrand Human Research 
Ethics Committee.  
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CHAPTER 3.0 RESULTS 
3.1 Incidence of asphyxia 
 
There were 23035 total live-births of which 21086 weighed ≥2000grams at birth. Of 
those weighing ≥2000g, 357 had a diagnosis of intrapartum asphyxia of which 321 were 
admitted and 36 died in labour ward before admission. Since the records of the latter 
were either missing or had incomplete information, they were excluded from the more 
detailed analysis but where included in the calculation of overall mortality rate only 
since my be reasonable to assume these infants died of asphyxia. The incidence of 
intrapartum asphyxia varied from 8.7 to 15.2/1000 deliveries depending on the definition 
of intrapartum asphyxia used (Table 2).  
 
Table 2 Incidence of asphyxia according to different definitions of intrapartum asphyxia 
(n=21086 live births >2000g) 
BMV – Bag Mask Ventilation  95% CI – 95% Confidence interval 
 
 
Definition 
 
Number of babies 
with  intrapartum 
asphyxia 
 
 
(per 1000 live births) 
   
Need for BMV at birth 
 
321 15.2[13.7,17.0] 
BMV and Base deficit >12 
mmol/L 
 
261 12.4[11.0,14.0] 
BMV and Apgar score <7 at 5 
minutes 
 
218 10.3[9.1,12.0] 
BMV, Apgar score <7 at 5 
minutes and Base deficit >12 
mmol/L 
 
183 8.7[7.5,10.0] 
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3.2 Maternal characteristics 
 
Demographic and clinical characteristics of mothers giving birth to infants diagnosed 
with intrapartum asphyxia are shown in Table 3. Most of the mothers (95.6%) attended 
antenatal care. Average maternal age was 25 years and 57.6% where pregnant for the 
first time. Just over a quarter of mothers (25.9%) where positive for human 
immunodeficiency virus (HIV). Among the mothers who had maternal illness recorded, 
the common diagnosis was pregnancy induced hypertension accounting for 75.9% of 
mothers with recorded illness and 19.6% of mothers giving birth to infants with a 
diagnosis of intrapartum asphyxia. Thirty four percent of babies with intrapartum 
asphyxia where born to mothers with meconium-stained amniotic fluid. The mode of 
delivery was CS in 38% of cases, with the most common reason for performing the CS 
was foetal distress (68.9%). Electronic monitoring with cardiotocograph was recorded 
in 77.6 % of mothers of which 47% where abnormal. In mothers with abnormal CTG, 
the common abnormality was late deceleration (76.9%) followed by early deceleration 
(6.8%) and foetal bradycardia (6.8%). 
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Table 3 Characteristics of mothers who delivered infants with intrapartum asphyxia 
 
 
Variables Numbers (%) 
 
 
Maternal age 
 
25.17 ±  6.4* 
Number of first pregnancies            185 (57.6) 
Number with positive HIV test 83 (25.9) 
Number received antenatal care 307 (95.6) 
Maternal illness 
- Hypertension 
- Other medical conditions 
 
63 (19.6) 
20 (6.2) 
Mode of delivery 
- Caesarean section 
- Vaginal delivery 
- Assisted vaginal delivery 
 
122 (38.0) 
171 (53.2) 
28 (8.7) 
Number with meconium stained amniotic fluid 110 (34.3) 
Documented electronic monitoring during labour CTG) 
- Yes 
- No 
 
249 (77.6) 
72 (22.4) 
Number with normal CTG in monitored patients 132/ 249 (53) 
Number with abnormal CTG in monitored patients 
- Late decelerations 
- Early decelerations 
- Fetal bradycardia 
- Beat to beat variability 
- Suspicious tracing 
117/ 249 (47) 
90/ 117 (76.9) 
  8/ 117 (6.8) 
  8/ 117 (6.8) 
  3/ 117 (2.6) 
  8/117 (6.8) 
 
* - Mean ± SD  CTG – Cardiotocograph 
 
3.3 Infant characteristics  
 
Average birth weight was 3084 grams with an average gestation of 39 weeks.(Table 4) 
3.3.1 Apgar scores 
 
Apgar scores were done at 1 minute and 5 minutes in 99.5% and at 10 minutes in 72.6% 
of babies. At 5 minutes 68.0% had an Apgar score of <7. Of those infants with 
documented Apgar score at 10 minutes, 29.7% had an Apgar of <7. 
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3.3.2 Resuscitation and time to spontaneous respiration 
 
During resuscitation, the majority (90%) of babies diagnosed with intrapartum asphyxia 
responded to BMV only, while 10% required extensive resuscitation in the form of 
chest compressions (7%) and adrenaline (3%). Among the infants who had time to 
spontaneous respiration recorded, 60% took >5 minutes to attain spontaneous 
respiration.  
3.3.3 Blood gases 
 
All infants were resuscitated with 100% oxygen. The majority of infants had blood gas 
analysis performed within an hour after delivery. The percentage of infants who did not 
have blood gas data recorded where roughly 7.5% and where excluded in the total 
number used in the analysis of the blood gas parameters. 
On blood gas analysis the mean partial pressure of oxygen (PaO2) and partial pressure 
of carbon dioxide (PaCO2) were 145 and 36 mmHg respectively. Only 24% had pH < 
7.00, 58% of infants had PaO2 of >100 mmHg, 53% had hypocarbia, PaCO2<35 mmHg 
and 80% had a base deficit >12 mmol/L. Only 59.8% of infants had a lactate 
documented in their file but since it is a good indicator of tissue hypoxia it is an 
important measurement to include in the analysis. Of those documented, 97.4% of the 
readings where found to be >7.5 mmol/l. 
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Table 4 Characteristics of infants diagnosed with intrapartum asphyxia 
 
 
Variables 
 
 
 
Number (%) 
Birth weight 3084 ±  448* 
Gestational age 38.5 ±  2.2* 
Sex 
- Male 
- Female 
 
192 (59.8) 
129 (40.2) 
Apgar score at 5 minutes 
- < 5 
- 5-7 
- ≥7 
 
75 (23.4) 
143 (44.6) 
 101 (31.5) 
Apgar score at 10 minutes 
- Recorded 
- < 5 
- 5-7 
- ≥7 
- Not recorded 
 
 233(72.6) 
19 (8.2) 
        50 (21.5) 
      164 (70.3) 
 88 (27.4) 
Resuscitation required 
- BMV only 
- BMV and CC 
- BMV + CC + Adrenalin 
 
288 (89.7) 
23 (7.2) 
10 (3.1) 
Time to spontaneous breathing 
- <5 minutes 
- 5-10 minutes 
- 10-20 minutes 
- >20 minutes 
- Not recorded 
 
105 (32.7) 
 89 (27.7) 
42 (13.1) 
27 (8.4) 
58 (18.1) 
pH 
- Number with pH <7.00 
- Number with pH 7.00 - 7.25 
- Number with pH >7.25 
- Not recorded 
7.09 ±0.16* 
  77 (24.0) 
182 (56.7) 
  38 (11.8) 
24(7.5) 
paO2 
- Number with paO2 <50 mmHg 
- Number with paO2 50 – 100 mmHg 
- Number with paO2 >100 mmHg 
145.63 ± 79.92* 
16 (5) 
92 (28.7) 
186 (57.9) 
paCO2 
- Number with paCO2 <35 mmHg 
- Number with paCO2 35 – 45 mmHg 
- Number with paCO2 >45 mmHg 
36.66 ± 16.71* 
170 (53.0) 
64 (19.9) 
62 (19.2) 
Base deficit 
- Number with Base deficit  ≤12mmol/L 
- Number with Base deficit  >12mmol/L 
18.09 ± 5.26* 
35 (10.9) 
261 (81.3) 
 
* - Mean ± SD BMV- Bag Mask Ventilation   CC- Chest Compression 
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3.4 Incidence of hypoxic ischemic encephalopathy and mortality 
 
The incidence of HIE ranged from 8.5 - 13.3/ 1000 live births depending on the 
definition of perinatal asphyxia used (Table 5). Defining perinatal asphyxia as Apgar 
score at 5 minutes <7 and base deficit >12 mmol/L, 179 patients (55.8%) developed 
signs of hypoxic ischemic encephalopathy, giving an incidence of 8.5/1000 live births 
compared to 13.3/1000 live births when using need for bag mask ventilation. Among 
those who developed HIE, 59% had moderate to severe HIE. The overall mortality rate 
including the deaths from labour ward was 14.2%. The mortality rate excluding the 
deaths from labour ward came to 7.8%, with the rates in infants with HIE ranging from 
8.9% to 12.3%, depending on the definition of intrapartum asphyxia used. Only 1.4% of 
infants with HIE 1 died compared to 7.1% and 62.5% in those with HIE 2 and 3 
respectively, defining intrapartum asphyxia with inclusion of metabolic acidaemia. There 
were no deaths among those who did not develop HIE. Sixty four percent of the deaths 
were primarily due to HIE, and 20% were due to HIE and MAS (Meconium Aspiration 
Syndrome) with or without PPHN (Persistent Pulmonary Hypertension of the Newborn 
and 24% were due to sepsis. Co-morbidities found in patients with asphyxia included 
renal dysfunction 31.2%; clinically presumed sepsis 24.6% and positive blood culture 
13.9%. 
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Table 5 Incidence of hypoxic ischemic encephalopathy and mortality rate in patients 
with intrapartum asphyxia defined as: 
 
 Need for bag mask ventilation Apgar score <7 and base deficit >12 
mmols/L 
 Total 
n (%) 
Incidence 
(per 1000 
live 
births) 
Number 
died, 
n(%) 
Total 
n (%) 
Incidence 
(per 1000 
live 
births) 
Number 
died, n (%) 
No 
HIE 
40 (12.5) - 0 (0) 4 (1.3) - 0 (0) 
HIE I 131 (40.8) 6.2 2 (1.5) 71 (22.1) 3.4 1 (1.4) 
HIE II 122 (38.0) 5.8 7 (5.7) 84 (26.2) 4.0 6 (7.1) 
HIE 
III 
28 (8.7) 1.3 16 (57.1) 24 (7.5) 1.1 15 (62.5) 
All 
HIEs 
281 (87.5) 13.3 25 (8.9) 179 (55.8) 8.5 22 (12.3) 
Overall Mortality Rate including deaths in labour ward =  14.2 % 
HIE- Hypoxic Ischemic Encephalopathy 
3.5  Association with HIE severity 
                                                                  
The comparison of HIE 1 and 2 with HIE 3 and /or death was made between the two 
groups for all patients with intrapartum asphyxia defined as need for BMV. On 
univariate analysis factors, there was no statistical significant differences in maternal 
characteristics and CTG readings between those with no HIE or mild to moderate 
compared to those with severe HIE or those who died. The infant factors that were 
associated with poor outcome (severe HIE or death) were low Apgar scores at 5 and 10 
minutes, need for chest compressions and adrenalin, delay in time to spontaneous 
respiration, low pH, high base deficit and low bicarbonate. Median Apgar score was 
lower at 5 minutes (4 vs. 6, p<0.01) and 10 minutes (5 vs. 8, p<0.01), time to 
spontaneous respiration was longer (15.4 min. vs. 6.2 min, p<0.01), pH was lower (6.9 
vs. 7.1, p<0.01), base deficit was higher (22.8 vs. 17.5 mmol/l) and bicarbonate was 
lower (8.9 vs. 11.6 mmol/l) in  
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Table 6 Factors associated with severe hypoxic ischemic encephalopathy HIE or death 
in infants with intrapartum asphyxia 
 
 
 HIE 1-2 
(n=256) 
HIE 3 and/or  
Death 
(n=37) 
P- value* P-value** 
 
Median Apgar at 5 
minutes 
 
 
6[IQR, 5-7] 
 
4[IQR, 3-5] 
 
<0.001 
 
0.99 
Median Apgar at 10 
minutes 
 
8[IQR, 7-8] 5[IQR, 4-7] <0.001 0.004 
Need for chest 
compressions 
 
61/256(23.8%) 22/37 (59.5%) <0.001 0.35 
Need for adrenalin 
 
1/256 (0.39%) 9/37 (24.3%) <0.001 0.03 
Time to spontaneous 
respiration (minutes) 
6.17 ± 5.71  15.36 ± 11.93 <0.001 0.69 
 
pH 
 
 
7.11 ± 0.14   
 
6.92 ± 0.18 
 
<0.001 
 
0.54 
PaO2 (mmHg) 145.25 ± 76.00 148.75 ± 108.35 0.82 N.S. 
 
PaCO2 (mmHg) 34.94 ± 13.89 49.91 ± 27.69 <0.001 0.33 
 
Bicarbonate  
(mmol/L) 
11.59 ± 2.84 8.91 ± 2.72 <0.001 0.03 
 
Base Deficit 
(mmol/L) 
 
 
17.48 ± 4.88 
 
22.74 ± 5.79 
 
<0.001 
 
0.30 
     
Lactate (mmol/L 15.90 ± 4.34 18.26 ± 3.68 0.008 0.61 
     
Glucose (mmol/L) 
 
6.79 ± 2.30 6.93 ± 4.48 0.82      N.S. 
 
* - Univariate analysis        ** - Multivariate analysis N.S. = Not significant 
± - Standard deviation      IQR – Inter-quartile range 
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infants with severe HIE and/ or death compared to those who survived to hospital 
discharge with no HIE or mild to moderate HIE (Table 6). Factors showing statistically 
significant differences in univariate analysis were included in a multivariate analysis to 
determine factors that could independently predict severity of HIE or death. Only Apgar 
score at 10 minutes (p=0.004), adrenaline (p=0.034) and bicarbonate levels in the first 
hour after birth (p=0.02) were found to be predictors of severe HIE and/or death. 
 
 
3.6 Severity of different variables and odds of developing severe HIE or death 
 
The odds of having severe HIE or death was  greater if Apgar score at 5 minutes was <5 
(OR 9.33; 95% CI 2.83 - 34.03); Apgar score at 10 minutes was 5-7 (OR 3.05; 95% CI 
1.08 - 8.62)  or was <5 (OR 19.1; 95% CI 5.66 - 66.9) compared to Apgar scores of >7; 
if required chest compressions (OR 8.36; 95% CI 3.71 – 19.1); if required adrenalin, 
(OR 81.2; 95% CI 13.2 - 647.7) and time to spontaneous respiration was more than 20 
minutes (OR 27.2; 95% CI 6.89 - 117.4). When arterial blood gas was done within the 
first hour of life the odds of having severe HIE and/or death were higher if the pH was 
<7 (OR 5.33; 95% CI 1.31 - 25.16, PaO2 <60 mmHg (OR 9.65; 95% CI 1.87 - 55.12) 
and PaCO2 >45 mmHg (OR 3.98; 95% CI 1.11 - 15.56) (Table 7).  
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Table 7 The odds ratio for developing severe hypoxic ischemic encephalopathy and/ or 
death with severity of different variables. 
 
Variables Odds ratio [95% Confidence interval] 
Apgar Score at 5 minutes    
>7 Reference 
5 to 7 1.79 [0.50, 7.01] 
<5 9.33 [2.83, 34.03] 
Apgar Score at 10 minutes  
 >7 Reference 
5 to 7 3.05 [1.08, 8.62] 
<5 19.13 [5.66, 66.89] 
Extent of Resuscitation  
 BMV only Reference 
Chest Compressions 8.36 [3.71, 19.1] 
Adrenaline 81.2 [13.17, 647.7] 
Time to Spontaneous Respiration  
 <5 minutes Reference 
5 to 10 minutes 2.18 [0.55, 9.24] 
10 to 20 minutes 3.41 [0.74, 16.20] 
>20 minutes 27.19 [6.89, 117.38] 
pH 
 >7.25 Reference 
7.0 – 7.2 1.48 [0.35, 7.13] 
<7.0 5.33 [1.31, 25.16] 
PaO2 (mmHg) 
 60 - 100 Reference 
>100 2.40 [0.63, 10.74] 
<60 9.65 [1.87, 55.12] 
PaCO2 (mmHg) 
 35 - 45 Reference 
>45 3.98 [1.11, 15.56] 
<35 0.75 [0.19, 3.07] 
BMV- Bag Mask Ventilation 
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CHAPTER 4.0  DISCUSSION  
 
The recent development of induced hypothermia to reduce the risk of mortality and 
disability in infants with intrapartum asphyxia prompted this study to assess the burden 
of intrapartum asphyxia (incidence of intrapartum asphyxia) and the numbers that might 
require cooling (incidence of moderate to severe HIE) in a setting where there is high 
patient load but limited resources. Defining intrapartum asphyxia as need for BMV, 
Apgar score <7 at 5 minutes and base deficit >12 mmol/l within an hour post-delivery, 
the incidence of asphyxia was 8.7/ 1000 live births. Most studies reporting on incidence 
of intrapartum asphyxia from developing countries do not include blood gases, and use 
only need for assistance with respiration and/or Apgar score <7 at 5 minutes. Using the 
definition of need for assistance with breathing or Apgar score <7 at 5 minutes the 
incidence of intrapartum asphyxia in this study was 15.2/1000 or 10.3/1000 live births 
respectively. Whichever definition is used, the incidence of intrapartum asphyxia in this 
study is very high compared to that reported in developed countries, which are at 1-
5/1000 live births.
[13, 14]
 We did not collect data on modifiable factors that might 
contribute to this high incidence of intrapartum asphyxia. A perinatal care survey 
conducted in SA in 2008-9 reported that delay in seeking medical care, inadequate 
monitoring during labour and lack of facilities are modifiable factors that were 
identified in neonates who died from intrapartum asphyxia.
[12]
   
The overall incidence of encephalopathy in infants with Apgar score <7 and base deficit 
>12mmol/L was 8.5/1000 live births, with 60% being due to HIE 2 and 3. The overall 
incidence reported in this study was higher than that reported in Sweden, a developed 
country and Kathmandu, Nepal, a developing country where the incidence was reported 
to be 1.8/ 1000 live births and 6.4/1000 live births respectively
[42, 43]
but lower than that 
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of 28.1/1000 that reported from Sarlahi, Nepal.
[44]
 It has been reported that among 
infants diagnosed with HIE, 15-20% will die in the neonatal period and 25-30% of 
survivors develop permanent neurodevelopmental abnormalities including cerebral 
palsy.
[14] 
In this study 62% and 7% of infants with HIE 3 and HIE 2 respectively died 
before hospital discharge. Some of the infants with HIE 2 and most of those with HIE 3 
who survive to hospital discharge will have a severe neurologic outcome. Therefore this 
high incidence of HIE in this report is a major concern and highlights the need for 
improvement in the healthcare system so that there is a reduced incidence of asphyxia 
and less HIE. It is also important to treat those with moderate to severe HIE with 
induced hypothermia to reduce neurologic disability and mortality.  
Predictors of severe HIE and/or deaths were low Apgar score at 10 minutes, need for 
adrenaline and low bicarbonate. Shah, et al reported similar findings and that need for 
chest compression, high base deficit and delayed onset of respiration more than 20 
minutes in infants with intrapartum asphyxia was associated with poor outcome. This 
study reported that the rates of severe adverse effects were 64% if one predictor was 
present and 76% if two were present and 93% if all three were present.
[32]
 The finding 
that Apgar score at 10 minutes is a predictor of poor outcome is helpful as the Apgar 
score is easy to perform and is widely used in labour and delivery rooms both in 
developed and developing countries. Though Apgar score has not been helpful in 
predicting infants who will develop cerebral palsy, especially in the era of using induced 
hypothermia for asphyxia,
[45]
 it has been shown to be of great assistance in predicting 
survival in both preterm and term infants. Laptook, et al reported that each point 
decrease in Apgar score at 10 minutes was associated with a 45% increase in the odds of 
death or disability, and concluded that Apgar score at 10 minutes provided useful 
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prognostic information before other evaluations are available.
[30]
 Presence of metabolic 
acidaemia or low bicarbonate is of additional value to Apgar score in predicting poor 
outcome, as Apgar score is often not done in real time and therefore can be unreliable. 
A base deficit of >16mmol/L has previously been reported to be a predictor of poor 
outcome.
[10]  
Casey, et al also reported that a combination of low Apgar score (0-3) and 
cord pH <7.0 increased the risk of mortality in both preterm and term infants.
[29] 
Sehdev, et al reported that a base deficit >16 mmol/L and a 5 minute Apgar score of <7 
concurrently, identified 79% of neonates who would develop complications.
[40]
 
 
Study limitations 
One of the chief limitations of this study is that it is a retrospective study. Therefore the 
diagnosis of intrapartum asphyxia and encephalopathy was mainly based on what was 
recorded in the patient’s hospital file. This might have led to overestimation of the true 
incidence of HIE especially as some clinical findings might be affected by the 
experience of a person conducting the examination. This overestimation is potentially 
affected by junior doctors commonly labelling infants with intrapartum asphyxia as 
having HIE.  
Another limitation was the exclusion of the 36 deaths in labour ward. These were 
included in the overall mortality rate calculation but were excluded in the total number 
of asphyxiated infants and in the calculation of the incidence of intrapartum asphyxia 
amongst others. Since the files of these patients could not be found, details surrounding 
the deaths were unclear. It might have been concluded that these deaths were due to 
severe intrapartum asphyxia but unfortunately it was unknown if there were any 
underlying confounding factors (e.g. congenital abnormalities, etc.) which could of 
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contributed to the cause of death other than perinatal asphyxia. This may have potential 
consequences especially with the calculation of incidence, since adding these deaths 
could increase number of asphyxiated infants by roughly 10% and therefore increasing 
the incidence of intrapartum asphyxia.  
A further limitation was that important data with regards to time to spontaneous 
respiration, blood gas analysis and Apgar score at 10 minutes where not found in 
18.1%, 7.5% and 27.4% respectively. This missing data would be valuable in the 
statistical analysis and fine tune it more, making the analysis more complete. Due to the 
absence of the data, the analysis was performed with the numbers available and 
analysed as closely as it could.  
Despite these limitations this study highlights the burden of intrapartum asphyxia and 
encephalopathy in our hospital and the need to attend to factors that might be 
contributing to this high incidence of intrapartum asphyxia. In addition it identifies areas 
in our management that might be contributing to high incidence of HIE namely use of 
100% oxygen and identifies information that might help when rationing use of intensive 
care beds and therapeutic hypothermia.    
CHAPTER 5.0  CONCLUSION AND RECOMMENDATIONS 
 
The incidences of both intrapartum asphyxia and hypoxic ischemic encephalopathy are 
very high in this CHBAH. As moderate to severe hypoxic-ischemic encephalopathy is 
more likely to be associated with abnormal neurodevelopmental outcomes and 
disability, factors that contribute to a high incidence of intrapartum asphyxia must be 
avoided. Those infants at risk of developing encephalopathy must be offered neuro-
protective treatment, namely induced hypothermia. Where arterial blood gas analysis, 
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intensive care facilities and induced hypothermia are not available or are limited, Apgar 
score <5 at 10 minutes, need for chest compressions and need for adrenalin can be of 
assistance in predicting poor outcome and in predicting need for counselling of families 
with a neonate with intrapartum asphyxia regarding prognosis and further interventions. 
Understanding the burden and outcomes of intrapartum asphyxia is important, so that 
one can be able to assess how much assistance is required towards its reduction and to 
identify factors associated with poor outcomes. Intrapartum asphyxia must be prevented 
as it is associated with high mortality rate especially in those with severe HIE, and 
survivors are more likely to have abnormal neurodevelopmental outcome. In addition to 
resuscitation and basic post-resuscitation care, induced hypothermia (neuro-protection) 
should be used in those with moderate to severe HIE in order to reduce mortality rate 
and incidence of abnormal neurodevelopmental outcome.  
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